Southern Derbyshire Shared Care Pathology Guidelines. Hypocalcaemia in Adults

Size: px
Start display at page:

Download "Southern Derbyshire Shared Care Pathology Guidelines. Hypocalcaemia in Adults"

Transcription

1 Southern Derbyshire Shared Care Pathology Guidelines Hypocalcaemia in Adults Purpose of Guideline The investigation and management of patients with newly diagnosed hypocalcaemia Definition Adjusted (corrected) calcium <2.20 mmol/l Corrected or Adjusted Calcium We report total calcium and corrected (adjusted for albumin) calcium results. All the calcium values in this guideline refer to the corrected values. This adjustment is only an approximation. The correction is not valid in acid-base disorders. For example although the corrected calcium may be normal in acute respiratory alkalosis, the ionised calcium may be low, and the patient may have symptoms of hypocalcaemia, such as parasthesia. When is hypocalcaemia considered a medical emergency? Adjusted Calcium mmol/l Not a medical emergency Adjusted Calcium mmol/l Possible medical emergency Adjusted Calcium <1.80 mmol/l Usually a medical emergency These limits are for guidance only; the severity of the patient s symptoms, and other factors, e.g. rapidity of the fall in calcium, renal function, will also determine whether the patient requires emergency admission. The laboratory will telephone all calcium results <2.00 mmol/l, Monday to Friday when GP practices are open. Calcium results <1.80 mmol/l will usually be telephoned to Derbyshire Health United when the GP practice is closed. When is hypocalcaemia suspected? Mild hypocalcaemia is not uncommon, and in many patients the only symptoms may be vague muscular aches and pains. Obviously the number and severity of symptoms will be dependent on the degree of hypocalcaemia. Severe symptoms such as tetany are rare, but parasthesia can be seen. Cardiovascular complications, arrhythmias, hypotension and heart failure can all be seen. Patients are at risk of hypocalcaemia if they have actual or functional Vitamin D deficiency. Authorised by Julia Forsyth Page 1 of 5

2 What are the causes of hypocalcaemia? Actual Vitamin D Deficiency o Dietary o Lack of Sunlight o Malabsorption, especially pancreatic disease and coeliac disease Functional Vitamin D Deficiency o Renal Disease (lack of 1-Hydroxylation) o Liver Disease (lack of 25-Hydroxylation) Magnesium deficiency Hypoparathyroidism o Autoimmune o Post Surgery What happens next? Adjusted Calcium <1.80 mmol/l (± symptoms) or <2.00 mmol/l (+ symptoms) The majority of patients need urgent referral to hospital, especially if symptomatic and/or if they have other co-morbidities. Adjusted Calcium mmol/l without symptoms If asymptomatic, immediate referral is not required. For patients presenting with hypocalcaemia without a known cause, dependent upon clinical details provided the laboratory measures: PTH Magnesium U & E Vitamin D Appropriate actions based on these results are shown in the flow chart below. Authorised by Julia Forsyth Page 2 of 5

3 Investigating New Hypocalcaemia Adjusted Calcium <1.80 mmol/l (± symptoms) or <2.0 mmol/l (+ symptoms) Urgent referral to hospital indicated Adjusted Calcium mmol/l (without symptoms) Immediate referral not indicated Measure PTH, Mg, U&E, Vitamin D Is PTH high? (> 65ng/L) No Check Vit D level Vitamin D deficiency very likely Check Vit D level Vit D deficiency alone is an unlikely cause of hypocalcaemia but suggest high dose replacement for completeness if Vitamin D <30 nmol/l: (100,000 units first day and then 20,000 units daily up to total dose of 300,000 units) Vitamin D <30 nmol/l High dose replacement required: 100,000 units first day and then 20,000 units daily up to total dose of 300,000 units If PTH not raised it is important to check for Mg deficiency, whatever the Vitamin D level Is Mg low? (< 0.70 mmol/l) No Magnesium Deficiency (PTH typically normal) Refer to Shared Care Hypomagnesaemia guideline Mg mmol/l oral replacement Mg <0.4 mmol/l i.v. replacement, i.e. admit patient same day or discuss with endocrinologist Is PTH low or low-normal? Hypocalcaemia with low / low-normal PTH and normal Mg suggests hypoparathyroidism. It is not common and can arise from autoimmune disease, infiltration, post-surgery and congenital causes. All newly diagnosed hypoparathyroidism should be referred to a Consultant Endocrinologist for full assessment and management plan Authorised by Julia Forsyth Page 3 of 5

4 Hypocalcaemia with raised PTH (>65 ng/l) Vitamin D deficiency is the usual diagnosis of hypocalcaemia with raised PTH. If the patient s renal function is normal the patient can present with a low serum phosphate (<0.8 mmol/l). The measurement of vitamin D itself is advised and treatment can commence straight away (please refer to Vitamin D guideline on the Shared Care Pathology Website). If renal, gastrointestinal or hepatic involvement is present the appropriate referral should be made when required. Hypocalcaemia with normal or decreased PTH (<65 ng/l) In patients with low serum calcium and a PTH within the reference range it is important to rule out magnesium deficiency, which gives rise to a blunted PTH response. Magnesium deficiency often requires correction to enable the calcium to be normalised (please refer to the hypomagnesaemia guideline on the Shared Care Pathology Website). In patients with low serum calcium, a PTH below the reference range is virtually diagnostic for hypoparathyroidism. Causes of Magnesium Deficiency Renal Loss Diuretics, especially Loop Diuretics Cytotoxic Drugs Aminoglycosides Immunosuppressants Miscellaneous drugs, e.g. PPI s, Bisphosphonates GI Severe Diarrhoea Malnutrition Alcoholism What Next? In patients at high risk of vitamin D deficiency (housebound, elderly, south Asian) with normal renal function and appropriately elevated PTH, treat with replacement doses of vitamin D and ensure adequate calcium is provided (see vitamin D guidelines). Otherwise, patients should be referred to an outpatient clinic depending on the initial assessment, for further investigation for an underlying cause and initiation of treatment. This may include correction of the underlying cause, calcium, vitamin D or vitamin D analogues. If renal impairment (CKD 3 or worse) refer to renal team If features of malabsorption refer to GI Otherwise refer to endocrinology Magnesium Deficiency: see separate guideline Vitamin D Deficiency: see separate guideline Authorised by Julia Forsyth Page 4 of 5

5 Contacts Duty Biochemist (8am to 7pm, Mon Fri) On Call Consultant Biochemist Via RDH switchboard, (24/7) Endocrinology Advice (9am 5pm, Mon Fri) Renal Registrar (9am to 9pm) via RDH switchboard bleep 8121 MAU and ACC OR MAU Nurse in Charge Authors: Rustam Rea, Roger Stanworth, Paul Masters, Nigel Lawson November 2011 Reviewed by: Date: Expiry date: Dr P Blackwell, Mrs H Seddon Nov th Nov 2015 Dr R Stanworth, Dr P Masters, Dr Mar st Mar 2018 P Blackwell, Mrs H Seddon Dr R Stanworth, Dr P Blackwell, Mrs H Seddon May st May 2020 Authorised by Julia Forsyth Page 5 of 5

Southern Derbyshire Shared Care Pathology Guidelines. Hyperkalaemia

Southern Derbyshire Shared Care Pathology Guidelines. Hyperkalaemia Southern Derbyshire Shared Care Pathology Guidelines Hyperkalaemia Purpose of Guideline Dealing with adult patients with Hyperkalaemia in the community Definition Serum potassium normal range is 3.5 5.3

More information

Southern Derbyshire Shared Care Pathology Guidelines. Hyperthyroidism

Southern Derbyshire Shared Care Pathology Guidelines. Hyperthyroidism Southern Derbyshire Shared Care Pathology Guidelines Hyperthyroidism Purpose of Guideline The management and referral criteria of patients with newly diagnosed hyperthyroidism. Background Hyperthyroidism

More information

Southern Derbyshire Shared Care Pathology Guidelines. Secondary Hypertension

Southern Derbyshire Shared Care Pathology Guidelines. Secondary Hypertension Southern Derbyshire Shared Care Pathology Guidelines Secondary Hypertension Purpose of Guideline This guideline covers the investigation and referral criteria of patients with suspected secondary causes

More information

Southern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism

Southern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism Southern Derbyshire Shared Care Pathology Guidelines Primary Hyperparathyroidism Please use this Guideline in Conjunction with the Hypercalcaemia Guideline Definition Driven by hyperfunction of one or

More information

Southern Derbyshire Shared Care Pathology Guidelines. Hypothyroidism

Southern Derbyshire Shared Care Pathology Guidelines. Hypothyroidism Southern Derbyshire Shared Care Pathology Guidelines Hypothyroidism Purpose of Guideline The management and referral criteria of patients with newly diagnosed hypothyroidism in adults. Background Hypothyroidism

More information

Southern Derbyshire Shared Care Pathology Guidelines. Hyponatraemia in Adults

Southern Derbyshire Shared Care Pathology Guidelines. Hyponatraemia in Adults Southern Derbyshire Shared Care Pathology Guidelines Hyponatraemia in Adults Purpose of Guideline The investigation and management of adult patients with newly diagnosed hyponatraemia. Hyponatraemia can

More information

Southern Derbyshire Shared Care Pathology Guidelines. Coeliac Disease

Southern Derbyshire Shared Care Pathology Guidelines. Coeliac Disease Southern Derbyshire Shared Care Pathology Guidelines Coeliac Disease Purpose of Guideline When and how to investigate patients for Coeliac Disease What the results mean When and how to refer patients Monitoring

More information

Clinical biochemistry of calcium and vitamin D

Clinical biochemistry of calcium and vitamin D Clinical biochemistry of calcium and vitamin D Dr Andrew Day Consultant in Clinical Biochemistry and Metabolic Medicine University Hospitals Bristol NHS Trust e-mail: andrew.day@uhbristol.nhs.uk A 48-year

More information

Southern Derbyshire Shared Care Pathology Guidelines. MGUS (Monoclonal Gammopathy of Undetermined Significance)

Southern Derbyshire Shared Care Pathology Guidelines. MGUS (Monoclonal Gammopathy of Undetermined Significance) Southern Derbyshire Shared Care Pathology Guidelines MGUS (Monoclonal Gammopathy of Undetermined Significance) Purpose of guideline This guideline provides information about the risk stratification of

More information

CLINICAL GUIDELINES ID TAG

CLINICAL GUIDELINES ID TAG CLINICAL GUIDELINES ID TAG Title: Treatment of Hypomagnesaemia in adults Author: Speciality / Division: Directorate: Dr Peter Sharpe, Dr Neal Morgan, Jillian Redpath Chemical Pathology/Nephrology/Pharmacy

More information

Investigations for Disorders of Calcium, Phosphate and Magnesium Homeostasis

Investigations for Disorders of Calcium, Phosphate and Magnesium Homeostasis Investigations for Disorders of Calcium, Phosphate and Magnesium Homeostasis Tutorial for Specialist Portfolio Biomedical Scientists 03/02/2014 Dr Petros Kampanis Clinical Scientist 1. Calcium Most abundant

More information

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff.

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff. Authoriser: Fiona Davidson Page 1 of 5 Hypercalcaemia Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff. Mild (usually no symptoms) 2.6 3.0 mmol/l Moderate

More information

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care Southern Derbyshire Shared Care Pathology Guidelines AKI guidelines for primary care Contents: Flow Diagram: Recommended response time to AKI warning stage test results for adults in primary care 2 Table

More information

Southern Derbyshire Shared Care Pathology Guidelines. Varicella Zoster Virus (VZV)

Southern Derbyshire Shared Care Pathology Guidelines. Varicella Zoster Virus (VZV) Southern Derbyshire Shared Care Pathology Guidelines Varicella Zoster Virus (VZV) Purpose of guideline This guideline provides information about the definition of significant exposure to VZV and management

More information

Shared Care Guideline Metolazone for fluid management in CKD (Adults)

Shared Care Guideline Metolazone for fluid management in CKD (Adults) Shared Care Guideline Metolazone for fluid management in CKD (Adults) It is vital for safe and appropriate patient care that there is a clear understanding of where clinical and prescribing responsibility

More information

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults. Consultation Group: See Page 4. Review Date: June 2021

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults. Consultation Group: See Page 4. Review Date: June 2021 NHS...... Grampian NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults Co-ordinators: Consultation Group: Approver:. Senior Medicines Information Pharmacist See Page 4 Medicine

More information

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff.

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff. Hypercalcaemia Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff. Mild (usually no symptoms) 2.6 3.0 mmol/l Moderate (start to develop symptoms) 3.0 3.4

More information

Southern Derbyshire Shared Care Pathology Guidelines. Dyslipidaemia

Southern Derbyshire Shared Care Pathology Guidelines. Dyslipidaemia Southern Derbyshire Shared Care Pathology Guidelines Dyslipidaemia This guideline applies to patients with significantly abnormal lipid profiles, which may be primary (genetic), secondary to other diseases

More information

Title of Guideline (must include the word Guideline Guideline for the Treatment of Hypokalaemia in Adults

Title of Guideline (must include the word Guideline Guideline for the Treatment of Hypokalaemia in Adults Title of Guideline (must include the word Guideline Guideline for the Treatment of (not protocol, policy, procedure etc) Hypokalaemia in Adults Contact Name and Job Title (author) Emily Snow, Pharmacist

More information

Prescribing Framework for Methotrexate for Immunosuppression in ADULTS

Prescribing Framework for Methotrexate for Immunosuppression in ADULTS Hull & East Riding Prescribing Committee Prescribing Framework for Methotrexate for Immunosuppression in ADULTS Patient s Name:.. NHS Number: Patient s Address:... (Use addressograph sticker) GP s Name:...

More information

ESCA: Denosumab for the treatment of osteoporosis in postmenopausal women.

ESCA: Denosumab for the treatment of osteoporosis in postmenopausal women. ESCA: Denosumab for the treatment of osteoporosis in postmenopausal women. Specialist details Patient identifier Name Tel: This effective shared care agreement (ESCA) sets out details for the sharing of

More information

1. Adults; a. Risk factors. b. Who should be tested for vitamin D deficiency? c. Investigations. d. Who do we treat and how do we treat? 2.

1. Adults; a. Risk factors. b. Who should be tested for vitamin D deficiency? c. Investigations. d. Who do we treat and how do we treat? 2. Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management For Adults and Children Adapted from existing local guidance, National Osteoporosis Society Practical Guides and from Royal

More information

NHS Grampian Staff Guideline For The Management Of Acute Hypophosphataemia In Adults

NHS Grampian Staff Guideline For The Management Of Acute Hypophosphataemia In Adults NHS Grampian Staff Guideline For The Management Of Acute Hypophosphataemia In Adults Co-ordinators: Medicine Information Pharmacist Consultation Group: See Page 5 Approver: Medicine Guidelines and Policies

More information

Endocrinology Update. Dr Colin Johnston Hon Consultant West Herts Trust

Endocrinology Update. Dr Colin Johnston Hon Consultant West Herts Trust Endocrinology Update Dr Colin Johnston Hon Consultant West Herts Trust colin.johnston2@nhs.net Thyrotoxicosis Symptoms GI symptoms-diarrhoea Fatigue Anxiety Irreg Menstruation Do not be put off the diagnosis

More information

GLUCOSE TOLERANCE TEST: FOR THE DIAGNOSIS OF DIABETES MELLITUS

GLUCOSE TOLERANCE TEST: FOR THE DIAGNOSIS OF DIABETES MELLITUS Title of Document: Glucose tolerance test: For Diagnosis of Mellitus Authoriser: Leila Cornes Page 1 of 6 GLUCOSE TOLERANCE TEST: FOR THE DIAGNOSIS OF DIABETES MELLITUS Introduction In most cases mellitus

More information

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults Co-ordinators: Sarah Gethings Medicine Information Pharmacist Consultation Group: See Page 4 Approver: Medicine Guidelines and

More information

NHS LINCOLNSHIRE in association with UNITED LINCOLNSHIRE HOSPITALS TRUST

NHS LINCOLNSHIRE in association with UNITED LINCOLNSHIRE HOSPITALS TRUST NHS LINCOLNSHIRE in association with UNITED LINCOLNSHIRE HOSPITALS TRUST SHARED CARE GUIDELINE: CINACALCET in the management of secondary hyperparathyroidism in adult patients with end-stage renal disease

More information

Biochemistry Department Laboratory Handbook

Biochemistry Department Laboratory Handbook Biochemistry Department Laboratory Handbook Version : 3.3 Page 1 of 12 Table of contents Biochemistry Department... 1 Laboratory Handbook... 1 Introduction... 3 The Biochemistry Department... 3 High risk

More information

Hyper and hypocalcaemia. Prof Tricia Tan

Hyper and hypocalcaemia. Prof Tricia Tan Hyper and hypocalcaemia Prof Tricia Tan Learning Objectives Basic physiology of Ca regulation Case presentations Take home messages Calcium Total body calcium content ~1300g 99% in bone 1% intracellular

More information

DENOSUMAB SHARED CARE GUIDLINES

DENOSUMAB SHARED CARE GUIDLINES DENOSUMAB LICENSING Denosumab (PROLIA ) is licensed for the treatment of osteoporosis in postmenopausal women at increased risk of fractures and for bone loss associated with hormone ablation in men with

More information

Magnesium Homeostasis

Magnesium Homeostasis ECTS PhD Training Course, Rome 3 rd September 2008 Disorders of Calcium, Phosphate h and Magnesium Homeostasis Richard Eastell Professor of Bone Metabolism Academic Unit of Bone Metabolism University of

More information

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT Phosphate Binders for the Treatment of Hyperphosphataemia in adults with Chronic Kidney Disease OBJECTIVES To outline referral

More information

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3.

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3. CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOPHOSPHATAEMIA IN ADULTS Summary. Key: General Notes GP/SWASFT ED/MAU/SRU/Acute GP/Amb-Care In-patient wards Start What is the serum concentration? Mild Hypophosphataemia

More information

CP80 Version: V01. Acute Oncology Management Service Date approved: 8 th May 2015 Date ratified: 1 st June 2015 Review date: 1 st June 2017

CP80 Version: V01. Acute Oncology Management Service Date approved: 8 th May 2015 Date ratified: 1 st June 2015 Review date: 1 st June 2017 STANDARD OPERATING PROCEDURE (SOP) AND PATHWAY FOR THE MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION (MSCC) WITHIN THE CHRISTIE (Refer to the Manchester Cancer Network MSCC Pathway flowchart)

More information

Guidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010

Guidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010 Guidelines to assist General Practitioners in the Management of Type 2 Diabetes April 2010 Foreword The guidelines were devised by the Diabetes Day Centre in Beaumont Hospital in consultation with a number

More information

Seasonal Influenza in Pregnancy and Puerperium Guideline (GL1086)

Seasonal Influenza in Pregnancy and Puerperium Guideline (GL1086) Seasonal Influenza in Pregnancy and Puerperium Guideline (GL1086) Approval Approval Group Job Title, Chair of Committee Date Maternity & Children s Services Clinical Governance Committee Chair, Maternity

More information

Palliative Care Emergencies

Palliative Care Emergencies Palliative Care Emergencies LAURA BARNFIELD What might constitute an emergency in Palliative Care? 1 Palliative Care Emergencies Major haemorrhage Metastatic Spinal Cord Compression (MSCC) Superior Vena

More information

Symptom management: Hypercalcemia

Symptom management: Hypercalcemia Symptom management: Hypercalcemia Dr Claire Higham 10.11.16 NLCFN National Conference 2016 Consultant Endocrinologist The Christie Hospital Manchester, UK Hypercalcemia of malignancy 2-30% of patients

More information

Essential Shared Care Agreement: Lithium

Essential Shared Care Agreement: Lithium Ref No. E042 Essential Shared Care Agreement: Lithium Please complete the following details: Patient s name, address, date of birth Treatment (indication, dose regimen, brand name) Monitoring (proposed

More information

Guideline on Diagnosis & Management of Vitamin D Deficiency in Adults for Non-Specialists

Guideline on Diagnosis & Management of Vitamin D Deficiency in Adults for Non-Specialists Guideline on Diagnosis & Management of Vitamin D Deficiency in Adults for Non-Specialists (Review date: April 2019) Contents Summary Flowchart... 2 Introduction... 3 Structure and mechanism of action of

More information

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 11

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 11 Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 11 Contents 11. Chronic Pancreatitis 138 11.1. Overview of management

More information

SUMMARY OF THE PRODUCT CHARACTERISTICS

SUMMARY OF THE PRODUCT CHARACTERISTICS SUMMARY OF THE PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Calcichew-D3 Mite Citron 500 mg/200 IU chewable tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One tablet contains: Calcium carbonate

More information

Guidelines for the Shared Care of Patients on hormonal therapy for Prostate Cancer

Guidelines for the Shared Care of Patients on hormonal therapy for Prostate Cancer Peterborough City Hospital Department of Urology Guidelines for the Shared Care of Patients on hormonal therapy for Prostate Cancer Hormonal Therapy - How does it work? Prostate Cancer relies on the presence

More information

Monash Health Referral Guidelines

Monash Health Referral Guidelines Monash Health Referral Guidelines CLINICAL NUTRITION EXCLUSIONS Services not offered by Monash Health Psychiatric management of eating disorders consider referring to Eating Disorders Unit Full diagnostic

More information

North Derbyshire OPAT (Outpatient Parenteral Antimicrobial Therapy) Pathway for Primary Care (Step-Up Pathway/Admission Avoidance)

North Derbyshire OPAT (Outpatient Parenteral Antimicrobial Therapy) Pathway for Primary Care (Step-Up Pathway/Admission Avoidance) North Derbyshire OPAT (Outpatient Parenteral Antimicrobial Therapy) Pathway for Primary Care (Step-Up Pathway/Admission Avoidance) Introduction OPAT services provide intravenous (IV) antibiotics to patients

More information

Guidelines for the Management of Hypomagnesaemia in Adult Haematology and Oncology Patients

Guidelines for the Management of Hypomagnesaemia in Adult Haematology and Oncology Patients Guidelines for the Management of Hypomagnesaemia in Adult Haematology and Version One Date of Publication: June 2011 Name of responsible committee/individual: Target audience: Date of Ratification: Original

More information

PACKAGE LEAFLET: Information for the patient. VITAMINE D2 Solution for injection IU / 1 ml (Ergocalciferol)

PACKAGE LEAFLET: Information for the patient. VITAMINE D2 Solution for injection IU / 1 ml (Ergocalciferol) PACKAGE LEAFLET: Information for the patient VITAMINE D2 Solution for injection - 300 000 IU / 1 ml (Ergocalciferol) Read this leaflet carefully before you start taking this medicine. - Keep this leaflet.

More information

GUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES

GUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES GUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target

More information

CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY& INSUFFICIENCY IN ADULTS

CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY& INSUFFICIENCY IN ADULTS CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY& INSUFFICIENCY IN ADULTS INTRODUCTION Vitamin D is essential for skeletal growth and bone health. Dietary sources in the UK are very

More information

Referral guide for acute oncology emergencies

Referral guide for acute oncology emergencies Referral guide for acute oncology emergencies 1 st Edition v 1.0 London Cancer March 2013 To be used in conjunction with London Cancer clinical guidelines for acute oncology emergencies; A Guide to Acute

More information

Glucose Tolerance Test (Non Pregnant Adult)

Glucose Tolerance Test (Non Pregnant Adult) Pathology at the Royal Derby Glucose Tolerance Test (Non Hospital Pregnant Adult) Standard Clinical Guidelines Chemical Pathology Valid Until 31 st March 2015 Document Code: CHISCG10 Glucose Tolerance

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Magnesium Trisilicate Mixture B.P. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Magnesium Trisilicate B.P. 250 mg/5 ml Light Magnesium

More information

Treatment monitoring protocol for Dimethyl fumarate therapy in active Relapsing Remitting Multiple Sclerosis

Treatment monitoring protocol for Dimethyl fumarate therapy in active Relapsing Remitting Multiple Sclerosis Treatment monitoring protocol for Dimethyl fumarate therapy in active Relapsing Remitting Multiple Sclerosis This protocol provides monitoring guidance for adult patients requiring Dimethyl fumarate therapy

More information

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Nutrition and Dietetic Service Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Authors Hilary Mathieson, Renal Dietitian Paul McKeveney, Consultant Nephrologist

More information

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU. Subject: Neutropenic Fever Guideline for Junior Doctors Date of Implementation: January 2010 Date of Review: January 2012 Director Responsible for Implementation and Review: Policy location: Consultant

More information

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST: Clinical Chemistry Guidelines

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST: Clinical Chemistry Guidelines Adrenocortical Insufficiency Guideline Document Information Policy Reference: Adrenocortical Insufficiency Issue: 1: Version 3 Author Job Title: Peter Prinsloo Consultant in Chemical Pathology STATUS:

More information

Hypocalcemia 6/8/12. Normal value. Physiologic functions. Nephron a functional unit of kidney. Influencing factors in Calcium and Phosphate Balance

Hypocalcemia 6/8/12. Normal value. Physiologic functions. Nephron a functional unit of kidney. Influencing factors in Calcium and Phosphate Balance Normal value Hypocalcemia Serum calcium Total mg/dl Ionized mg/dl Cord blood 9.0 ~ 11.5 5.0 ~ 6.o New born (1 st 24 hrs) 9.0 ~ 10.6 4.3 ~ 5.1 24~ 48 hrs 7.0 ~12.0 4.0 ~4.7 Child 8.8 ~10.8 4.8 ~4.92 There

More information

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY Specialist details Patient identifier Name Tel: EFFECTIVE SHARE CARE AGREEMENT FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY The aim of Effective Shared Care Guidelines

More information

Low risk upper GI bleeding pathway

Low risk upper GI bleeding pathway Low risk upper GI bleeding pathway Background Low risk upper GI bleeding may be safely managed without an emergency admission to NUH following presentation to the ED. NUH uses the Glasgow Blatchford score

More information

Greater Manchester Interface Prescribing Group Shared Care Template

Greater Manchester Interface Prescribing Group Shared Care Template Greater Manchester Interface Prescribing Group Shared Care Template Shared Care Guideline the use of Denosumab for the prevention of osteoporotic fractures in postmenopausal women. Author(s)/Originator(s):

More information

Arthroscopic rotator cuff repair

Arthroscopic rotator cuff repair Arthroscopic rotator cuff repair This leaflet aims to answer some of the questions you may have about having an arthroscopic rotator cuff repair. It explains the benefits, risks and alternatives to the

More information

Intravenous anti-cancer treatment

Intravenous anti-cancer treatment Intravenous anti-cancer treatment Information for patients Chemotherapy Name Hospital No Your consultant is Anti-cancer treatment is the term used to describe medicines used to treat cancer including chemotherapy.

More information

ESPEN Congress Geneva 2014 The undesirable weight loss: malnutrition in bariatric patients. A case presentation F. Pralong (CH)

ESPEN Congress Geneva 2014 The undesirable weight loss: malnutrition in bariatric patients. A case presentation F. Pralong (CH) ESPEN Congress Geneva 2014 The undesirable weight loss: malnutrition in bariatric patients A case presentation F. Pralong (CH) The undesirable weight loss: malnutrition in bariatric patients A case presentation

More information

Inpatient Pediatric Endocrinology. Tala Dajani MD MPH Pediatric Endocrinology of Phoenix

Inpatient Pediatric Endocrinology. Tala Dajani MD MPH Pediatric Endocrinology of Phoenix Inpatient Pediatric Endocrinology Tala Dajani MD MPH Pediatric Endocrinology of Phoenix Objectives Identify calcium disorders in the hospital Distinguish between temporary versus permanent glucose problems

More information

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:... Coping, now your chemotherapy is finishing [ovarian cancer] Patient Information Series PI 41a East and North Hertfordshire NHS Trust 2 Contacts Chemotherapy Suite:... 020 3826 2236 [Mon - Fri, 8.00am -

More information

SUMMARY OF THE PRODUCT CHARACTERISTICS

SUMMARY OF THE PRODUCT CHARACTERISTICS SUMMARY OF THE PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Recikalc-D forte 500 mg/ 800 IU chewable tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each chewable tablet contains calcium

More information

Vitamin D Deficiency

Vitamin D Deficiency PATIENT INFORMATION LEAFLET Vitamin D Deficiency What is vitamin D? Vitamin D is essential for good health, strong bones and muscles. Unlike other vitamins, we do not need to get vitamin D from food. Our

More information

Package leaflet: Information for the user. Zoledronic Acid Accord 4 mg/5 ml concentrate for solution for infusion Zoledronic acid

Package leaflet: Information for the user. Zoledronic Acid Accord 4 mg/5 ml concentrate for solution for infusion Zoledronic acid Package leaflet: Information for the user Zoledronic Acid Accord 4 mg/5 ml concentrate for solution for infusion Zoledronic acid Read all of this leaflet carefully before you start taking this medicine

More information

Guidance for Thyroid Function Testing in Primary Care in Lothian

Guidance for Thyroid Function Testing in Primary Care in Lothian Guidance for Thyroid Function Testing in Primary Care in Lothian In July 2006 following a lengthy consultation process, a joint working group comprising representatives from the Association of Clinical

More information

LRI Children s Hospital

LRI Children s Hospital LRI Children s Hospital Management of Henoch Schönlein Purpura (HSP) in children Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team approval date: July 2017 Version: V 3

More information

qthis medicinal product is subject to additional monitoring. This will allow quick identification of new safety

qthis medicinal product is subject to additional monitoring. This will allow quick identification of new safety Parsabiv q (etelcalcetide) Frequently Asked Questions qthis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Colecalciferol Meda 800 IU tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains colecalciferol (vitamin D 3 ) 800 IU

More information

Case Reports. A Rare Cause of Symptomatic Neonatal Hypocalcaemia EKC YAU, AWF CHENG, SY LEE, CB CHOW. Abstract. Key words.

Case Reports. A Rare Cause of Symptomatic Neonatal Hypocalcaemia EKC YAU, AWF CHENG, SY LEE, CB CHOW. Abstract. Key words. HK J Paediatr (new series) 2003;8:121-125 Case Reports A Rare Cause of Symptomatic Neonatal Hypocalcaemia EKC YAU, AWF CHENG, SY LEE, CB CHOW Abstract Key words Neonatal hypocalcaemia due to maternal hyperparathyroidism

More information

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Dumfries and Galloway. Treatment Protocol for Osteoporosis Dumfries and Galloway Treatment Protocol for Osteoporosis DIAGNOSIS OF OSTEOPOROSIS 2 Diagnostic Criteria 2 REFERRAL CRITERIA FOR DEXA 3 TREATMENT 4 Non-Drug Therapy : for all 4 Non-Drug Therapy : in the

More information

Rituximab treatment in autoimmune blistering diseases

Rituximab treatment in autoimmune blistering diseases Rituximab treatment in autoimmune blistering diseases This leaflet explains more about having treatment with the medicine rituximab for an autoimmune blistering disease. It includes information about the

More information

Western Locality Shared care Information ~ Penicillamine, Rheumatology April 2013

Western Locality Shared care Information ~ Penicillamine, Rheumatology April 2013 Western Locality Shared care Information ~ Penicillamine, Rheumatology April 2013 Penicillamine Treatment of: Rheumatoid arthritis Specialist: Please complete the Shared Care letter sending a request to

More information

Vitamin D deficiency: Altavita D3 - A range designed for compliance

Vitamin D deficiency: Altavita D3 - A range designed for compliance Vitamin D deficiency: Altavita D3 - A range designed for compliance Patient information Licensed for prevention and treatment of vitamin D deficiency Abbreviated prescribing information can be found on

More information

Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy)

Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy) Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy) Patient information Oxford Kidney Unit If you have been told you have chronic kidney disease (CKD) due to diabetic nephropathy this leaflet

More information

Referral and Ongoing Care for Children with Suspected Diabetes

Referral and Ongoing Care for Children with Suspected Diabetes South West Paediatric Diabetes Regional Network Pathway for Referral and Ongoing Care for Children with Suspected Diabetes Dear Colleagues, On behalf of the South West Paediatric Diabetes Network, I m

More information

LRI Children s Hospital

LRI Children s Hospital Calcium Disorders in Children LRI Children s Hospital Staff relevant to: Medical & Nursing staff caring for Children identified with having a Calcium disorder Team approval date: January 2019 Version:

More information

A Case of Severe Hypomagnesemia with Long-term Use of a Proton Pump Inhibitor

A Case of Severe Hypomagnesemia with Long-term Use of a Proton Pump Inhibitor A Case of Severe Hypomagnesemia with Long-term Use of a Proton Pump Inhibitor Amy Trottier University of Calgary Internal Medicine, PGY1 November 14, 2013 2013 Rocky Mountain/ACP Internal Medicine Conference

More information

Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures

Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures Clinical Guidelines Management of adult patients with diabetes undergoing endoscopic s Document Detail Document type Clinical Guideline Management of adult Patients with diabetes Undergoing Document name

More information

Dept of Diabetes Main Desk

Dept of Diabetes Main Desk Dept of Diabetes Main Desk 01202 448060 Glucose management in Type 2 Diabetes in Adults The natural history of type 2 diabetes is for HbA1c to deteriorate with time. A stepwise approach to treatment is

More information

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Dumfries and Galloway. Treatment Protocol for Osteoporosis Dumfries and Galloway Treatment Protocol for Osteoporosis DIAGNOSIS OF OSTEOPOROSIS 2 Diagnostic Criteria 2 Multiple low trauma vertebral fractures in the absence of myeloma or metastatic disease. 2 T-score

More information

Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant

Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant All medical RCC transfusions (but only 1 in 3 haematology or oncology cases) in 3 x one week periods Medical specialties include:

More information

Hypoparathyroidism By John Halpern, DO, FACEP Coauthored by N. Ewen Wang, MD

Hypoparathyroidism By John Halpern, DO, FACEP Coauthored by N. Ewen Wang, MD Hypoparathyroidism By John Halpern, DO, FACEP Coauthored by N. Ewen Wang, MD Reprinted with permission from: E-Medicine: Instant Access to the Minds of Medicine http://www.emedicine.com/emerg/topic276.htm

More information

Brunel Health Core Ten Results for Sam Witter. Thank you for submitting a sample of your blood to be tested by Brunel Health.

Brunel Health Core Ten Results for Sam Witter. Thank you for submitting a sample of your blood to be tested by Brunel Health. Brunel Health Core Ten Results for Sam Witter Dear Sam, Thank you for submitting a sample of your blood to be tested by Brunel Health. We are pleased to say that there was enough viable sample to test

More information

Specialist Palliative Care Referral for Patients

Specialist Palliative Care Referral for Patients Specialist Palliative Care Referral for Patients This guideline covers referrals for patients with progressive terminal illness, whether due to cancer or other disease. For many patients in the late stages

More information

Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway

Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway Dr Alex Williams, Oncology Specialty Doctor. Cheltenham General Hospital Oncology Centre

More information

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Update on Management of Malignant Spinal Cord Compression Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Current Guidelines The symptoms of MSCC may be subtle and therefore careful

More information

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care Berkshire West Integrated Care System Representing Berkshire West Clinical Commisioning Group Royal Berkshire NHS Foundation Trust Berkshire Healthcare NHS Foundation Trust Berkshire West Primary Care

More information

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014 Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014 Introduction The Integrated Community Diabetes Service (ICDS) will deliver high quality care to individuals who

More information

HYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences

HYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences HYPERCALCEMIA Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences ESSENTIALS OF DIAGNOSIS Serum calcium level > 10.5 mg/dl Serum ionized

More information

S H A R E D C A R E G U I D E L I N E Drug: Denosumab 60mg injection Indication: treatment of osteoporosis in postmenopausal women

S H A R E D C A R E G U I D E L I N E Drug: Denosumab 60mg injection Indication: treatment of osteoporosis in postmenopausal women S H A R E D C A R E G U I D E L I N E Drug: Denosumab 60mg injection Indication: treatment of osteoporosis in postmenopausal women Introduction Indication: Denosumab (Prolia ) is recommended in NICE TA204

More information

Warwickshire Dietetic Service Referral Criteria

Warwickshire Dietetic Service Referral Criteria Warwickshire Dietetic Service Referral Criteria Author: Anne Davidson Dietetic Service Manager Developed June 2008 Reviewed August 2010/June 2011 Rewritten - May 2012(Countywide) Referrals are accepted

More information

ESCA: Cinacalcet (Mimpara )

ESCA: Cinacalcet (Mimpara ) ESCA: Cinacalcet (Mimpara ) Effective Shared Care Agreement for the Treatment of Primary hyperparathyroidism when parathyroidectomy is contraindicated or not clinically appropriate. Specialist details

More information

PERIOPERATIVE DIABETES GUIDELINE

PERIOPERATIVE DIABETES GUIDELINE PERIOPERATIVE DIABETES GUIDELINE This Guideline does not replace the need for the application of clinical judgment in respect to each individual patient. Background Diabetes mellitus is estimated to affect

More information

Dosage in renal impairment Kalcipos-D chewable tablets should not be used in patients with severe renal impairment.

Dosage in renal impairment Kalcipos-D chewable tablets should not be used in patients with severe renal impairment. SUMMARY OF THE PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Kalcipos-D 500 mg/400 IU chewable tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One chewable tablet contains: calcium 500 mg as

More information

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Contents: Blood disorders 1 1. Anaemia 2 A. Non-renal patients 2 B. Patients with chronic kidney disease under the care of

More information